Fulcrum Therapeutics, Inc. (FULC)

NASDAQ: FULC · IEX Real-Time Price · USD

8.00

-0.12 (-1.48%)

At close: Jul 19, 2024, 4:00 PM

7.89

-0.11 (-1.38%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Fulcrum Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2017
Net Income	-99.43	-97.34	-109.87	-80.85	-70.82	-89.81	Upgrade
Depreciation & Amortization	2.09	2.17	2.41	2.52	2.38	2.05	Upgrade
Share-Based Compensation	14.47	14.8	13.35	11.07	7.35	4.22	Upgrade
Other Operating Activities	-9.26	-10.6	-2.94	-11.22	7.44	36.92	Upgrade
Operating Cash Flow	-92.13	-90.97	-97.05	-78.48	-53.66	-39.48	Upgrade
Capital Expenditures	-0.37	-0.51	-1.96	-1.71	-1.34	-0.85	Upgrade
Acquisitions	0	0	0	0	0	-0.09	Upgrade
Change in Investments	95.74	-36.18	14.38	-127.96	-55.8	0	Upgrade
Investing Cash Flow	95.38	-36.69	12.41	-129.67	-57.14	-0.94	Upgrade
Share Issuance / Repurchase	2.08	118.12	84.32	186.53	71.18	64.42	Upgrade
Debt Issued / Paid	0	0	0	-0.02	-0.05	-0.05	Upgrade
Other Financing Activities	-	-	-	-	-	-0.03	Upgrade
Financing Cash Flow	2.08	118.12	84.32	186.51	71.13	64.34	Upgrade
Net Cash Flow	5.32	-9.54	-0.31	-21.64	-39.66	23.92	Upgrade
Free Cash Flow	-92.5	-91.47	-99.01	-80.19	-55	-40.34	Upgrade
Free Cash Flow Margin	-3685.18%	-3261.07%	-1561.23%	-418.47%	-623.34%	-	Upgrade
Free Cash Flow Per Share	-1.49	-1.49	-2.20	-2.27	-2.17	-3.65	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).